is januvia a glp 1 agonist Sitagliptin/Metformin (Janumet) as Combination Therapy In the Treatment of Type-2 Diabetes Mellitus Comparing Ozempic, Wegovy and Other

In clinical trials, it led to a weight reduction of up to 16.2%

If the clinician determines Microdose isn't right for you, they may recommend a different protocol your monthly billing only changes if your clinician switches you to a different compound

These specific strains may help support insulin sensitivity, blood sugar balance, appetite regulation, and metabolic efficiency

Larger randomized controlled trials with long-term follow-up are necessary to confirm these associations and evaluate the risk-benefit ratios

Methods Adults (18 years old) with T2D required at least one prescription for injectable semaglutide at index date (treatment switch), at least one prescription for any other GLP-1 RA in the previous 365 days, a baseline HbA1c and/or weight measurement in the 90 days pre-index and a follow-up measurement at 180 and 365 days post-index

ICD-10 codes to identify the outcome are included in supplementary table S1